11
Oct
2017

George Yancopoulos on Threading the Price Needle, and Building a Biotech to Last

Please subscribe and tell your friends why it’s worthwhile. Quality journalism costs money. When you subscribe to Timmerman Report at $169 per year, you reward quality independent biotech reporting, and encourage more.

 
 

You may also like

Writing in the Language of DNA: Kevin Ness on The Long Run
Blazing a New Trail in Psychiatry & Women’s Health: Jeff Jonas on The Long Run
Life of a Scientific Entrepreneur: Bob Langer of MIT on The Long Run
Seeing Lots of Single Cells, Up Close: Serge Saxonov of 10X Genomics on The Long Run